Sign in or Register   Sign in or Register
  |  

Mouse Anti-IRAK1 Recombinant Antibody (3A9) (CBMAB-A4510-LY)

The product is antibody recognizes IRAK1. The antibody 3A9 immunoassay techniques such as: WB, ELISA.
See all IRAK1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
3A9
Antibody Isotype
IgG2a, κ
Application
WB, ELISA

Basic Information

Immunogen
IRAK1 (AAH54000, 530 a.a. ~ 693 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Interleukin 1 Receptor Associated Kinase 1
Introduction
This gene encodes the interleukin-1 receptor-associated kinase 1, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This gene is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
Entrez Gene ID
UniProt ID
Alternative Names
IRAK; pelle
Function
Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.
Biological Process
Activation of NF-kappaB-inducing kinase activityManual Assertion Based On ExperimentIDA:UniProtKB
AgingIEA:Ensembl
Cellular response to heatIEA:Ensembl
Cellular response to hypoxiaIEA:Ensembl
Cellular response to lipopolysaccharideManual Assertion Based On ExperimentIBA:GO_Central
Cytokine-mediated signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Innate immune responseManual Assertion Based On ExperimentIBA:GO_Central
Interleukin-1-mediated signaling pathwayManual Assertion Based On ExperimentIMP:BHF-UCL
Intracellular signal transductionManual Assertion Based On ExperimentIBA:GO_Central
JNK cascadeIEA:Ensembl
Lipopolysaccharide-mediated signaling pathwayManual Assertion Based On ExperimentIMP:BHF-UCL
MyD88-dependent toll-like receptor signaling pathwayManual Assertion Based On ExperimentTAS:BHF-UCL
Negative regulation of NF-kappaB transcription factor activityManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of I-kappaB kinase/NF-kappaB signalingManual Assertion Based On ExperimentIMP:MGI
Positive regulation of leukocyte adhesion to vascular endothelial cellManual Assertion Based On ExperimentIMP:ARUK-UCL
Positive regulation of MAP kinase activityManual Assertion Based On ExperimentIBA:GO_Central
Positive regulation of NF-kappaB transcription factor activityManual Assertion Based On ExperimentIDA:BHF-UCL
Positive regulation of NIK/NF-kappaB signalingManual Assertion Based On ExperimentIMP:ARUK-UCL
Positive regulation of smooth muscle cell proliferationIEA:Ensembl
Positive regulation of type I interferon productionManual Assertion Based On ExperimentIMP:BHF-UCL
Protein autophosphorylationManual Assertion Based On ExperimentIDA:BHF-UCL
Protein phosphorylationManual Assertion Based On ExperimentTAS:ProtInc
Regulation of cytokine-mediated signaling pathwayManual Assertion Based On ExperimentIMP:BHF-UCL
Response to interleukin-1Manual Assertion Based On ExperimentIMP:BHF-UCL
Response to lipopolysaccharideManual Assertion Based On ExperimentIMP:BHF-UCL
Toll-like receptor 2 signaling pathwayManual Assertion Based On ExperimentIMP:BHF-UCL
Toll-like receptor 4 signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Toll-like receptor 9 signaling pathwayTAS:Reactome
Toll-like receptor signaling pathwayTAS:Reactome
Type I interferon signaling pathwayManual Assertion Based On ExperimentIMP:BHF-UCL
Cellular Location
Cytoplasm; Nucleus; Lipid droplet. Translocates to the nucleus when sumoylated. RSAD2/viperin recruits it to the lipid droplet (By similarity).
PTM
Following recruitment on the activated receptor complex, phosphorylated on Thr-209, probably by IRAK4, resulting in a conformational change of the kinase domain, allowing further phosphorylations to take place. Thr-387 phosphorylation in the activation loop is required to achieve full enzymatic activity.
Polyubiquitinated by TRAF6 after cell stimulation with IL-1-beta by PELI1, PELI2 and PELI3. Polyubiquitination occurs with polyubiquitin chains linked through 'Lys-63'. Ubiquitination promotes interaction with NEMO/IKBKG. Also sumoylated; leading to nuclear translocation.

Schagdarsurengin, U., Breiding, V., Loose, M., Wagenlehner, F., & Dansranjav, T. (2022). Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer. Frontiers in Oncology, 12, 991368.

Scarneo, S. A., Hughes, P. F., Yang, K. W., Carlson, D. A., Gurbani, D., Westover, K. D., & Haystead, T. A. (2020). A highly selective inhibitor of interleukin-1 receptor–associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase. Journal of Biological Chemistry, 295(6), 1565-1574.

Long, J. P., Dong, L. F., Chen, F. F., & Fan, Y. F. (2019). miR‑146a‑5p targets interleukin‑1 receptor‑associated kinase 1 to inhibit the growth, migration, and invasion of breast cancer cells. Oncology letters, 17(2), 1573-1580.

Yin, D., Chen, Y., Li, Y., Lu, R., Wang, B., Zhu, S., ... & Xu, Z. (2019). Interleukin-1 receptor associated kinase 1 mediates the maintenance of neuropathic pain after chronic constriction injury in rats. Neurochemical Research, 44, 1214-1227.

Wang, Y., Wang, Y., Duan, X., Wang, Y., & Zhang, Z. (2018). Interleukin‐1 receptor‐associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma. Journal of Cellular Biochemistry, 119(3), 2545-2555.

Zhou, Z., Tian, Z., Zhang, M., Zhang, Y., Ni, B., & Hao, F. (2018). Upregulated IL-1 receptor-associated kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential. Immunological Investigations, 47(5), 468-483.

Hosseini, M. M., Kurtz, S. E., Abdelhamed, S., Mahmood, S., Davare, M. A., Kaempf, A., ... & Agarwal, A. (2018). Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia, 32(11), 2374-2387.

Singer, J. W., Fleischman, A., Al-Fayoumi, S., Mascarenhas, J. O., Yu, Q., & Agarwal, A. (2018). Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy. Oncotarget, 9(70), 33416.

De, S., Karim, F., Kiessu, E., Cushing, L., Lin, L. L., Ghandil, P., ... & Rao, V. R. (2018). Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling. Journal of Biological Chemistry, 293(39), 15208-15220.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-IRAK1 Recombinant Antibody (3A9)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare